StonvexLoading…
StonvexStonvexStonvexCore line items from PDLB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-23 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | Not available | $48.66M | $185.53M | $136.70M | $89.86M |
Operating Income | Not available | $11.37M | $38.43M | $24.73M | $15.97M |
Net Income | Not available | $8.62M | $28.70M | $18.57M | $6.10M |
EPS (Diluted) | $0.24 | $0.36 | $1.20 | $0.77 | $0.50 |
Total Assets | Not available | $3.30B | $3.22B | $3.16B | $3.15B |
Total Liabilities | Not available | $2.75B | $2.68B | $2.63B | $2.63B |
Cash & Equivalents | Not available | $117.25M | $126.15M | $146.58M | $126.64M |
Free Cash Flow OCF − CapEx | Not available | $13.83M | $54.62M | $19.64M | $18.85M |
Shares Outstanding | Not available | 24.19M | 24.14M | 24.00M | 23.98M |